Disruption of the pro-oncogenic c-RAF-PDE8A complex represents a differentiated approach to treating KRAS-c-RAF dependent PDAC. (2024)
Attributed to:
Glasgow – Confidence in Concept 2019
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41598-024-59451-3
PubMed Identifier: 38637546
Publication URI: http://europepmc.org/abstract/MED/38637546
Type: Journal Article/Review
Volume: 14
Parent Publication: Scientific reports
Issue: 1
ISSN: 2045-2322